BioSpace News Archive

Mouse Embryo Assay Provides Proof of Concept Comparing Conventional Dewars and TMRW’s Cryo Robot

Aevi Genomic Medicine, Inc. announced that the Nasdaq Hearings Panel has agreed to the transfer of the Company’s shares to the Nasdaq Capital Market effective at the open of business on October 15, 2019 and granted the Company until February 3, 2020 to gain and evidence compliance of the Nasdaq Capital Market continued listing requirements..

At 5:00 p.m. Eastern Time (ET), senior management will host a conference call to review the Company’s financial performance.

The Office of the National Coordinator for Health IT (ONC) has named Surescripts as an ONC Program Partner for Electronic Prescribing (45 C.F.R. § 170.315(b)(3)) and approved Surescripts as an alternative test method to the ONC-Authorized Testing Laboratory (ONC-ATL).

Presentations to demonstrate company’s continued commitment to enabling discoveries and improving run times, performance and affordability with new PCR, qPCR and NGS reagents

This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention

Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, announced the publication of two key studies.

Company Also Expands Sales Team to Include Five Leaders with Extensive Neurovascular Experience

ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the third quarter 2019

LabCorp® announced that it will mark its 50th anniversary at a celebration Oct. 15 in Burlington, North Carolina, where the company has been headquartered since its founding. Dr. James B. Powell and his brothers, Dr. Thomas Edward Powell III and John Powell, founded LabCorp’s predecessor company, Biomedical Laboratories, in the former Alamance General Hospital building and tested the company’s first specimens on Oct.